K
Kenji Nakamichi
Researcher at University of Washington
Publications - 9
Citations - 82
Kenji Nakamichi is an academic researcher from University of Washington. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 3, co-authored 5 publications receiving 26 citations.
Papers
More filters
Journal ArticleDOI
Hospitalization and mortality associated with SARS-CoV-2 viral clades in COVID-19.
Kenji Nakamichi,Jolie Z. Shen,Cecilia S Lee,Aaron Y. Lee,Emma A. Roberts,Paul D. Simonson,Pavitra Roychoudhury,Jessica Andriesen,April K. Randhawa,Patrick C. Mathias,Alexander L. Greninger,Alexander L. Greninger,Keith R. Jerome,Keith R. Jerome,Russell N. Van Gelder +14 more
TL;DR: In this paper, the authors applied statistical and machine learning models to determine whether SARS-CoV-2 sequence variants are associated with differing outcomes among COVID-19 patients in a single medical system.
Journal ArticleDOI
Prognostic Utility of Whole-Genome Sequencing and Polymerase Chain Reaction Tests of Ocular Fluids in Postprocedural Endophthalmitis.
Cecilia S Lee,Bryan K. Hong,Sundeep K. Kasi,Christopher M. Aderman,Katherine E. Talcott,Murtaza K. Adam,Bryan Yue,Lakshmi Akileswaran,Kenji Nakamichi,Yue Wu,Kasra A. Rezaei,Lisa C. Olmos de Koo,Yewlin E. Chee,Aaron Y. Lee,Sunir J. Garg,Russell N. Van Gelder +15 more
TL;DR: Presence and higher load of bacteria other than S. epidermidis detected by WGS or DNA from TTV by qPCR in ocular fluids is associated with worse outcomes in post-procedure endophthalmitis.
Journal ArticleDOI
Deep metagenomic sequencing for endophthalmitis pathogen detection using a nanopore platform
Liying Low,Kenji Nakamichi,Lakshmi Akileswaran,Cecilia S Lee,Aaron Lee,George Moussa,Philip I. Murray,Graham R. Wallace,Russell N. Van Gelder,Saaeha Rauz +9 more
TL;DR: In this paper , the utility of nanopore sequencing for identifying potential causative pathogens in endophthalmitis was evaluated by comparing culture results with full-length 16S rRNA nanopore, whole genome nanopore WGS, and Illumina (Illumina WGS).
Posted ContentDOI
Outcomes associated with SARS-CoV-2 viral clades in COVID-19
Kenji Nakamichi,Jie Shen,Cecilia S Lee,Aaron Y. Lee,Emma A. Roberts,Paul D. Simonson,Pavitra Roychoudhury,Jessica Andriesen,April K. Randhawa,Patrick C. Mathias,Alexander L. Greninger,Alexander L. Greninger,Keith R. Jerome,Keith R. Jerome,Van Gelder Rn,Van Gelder Rn +15 more
TL;DR: SARS-CoV-2 shows substantial sequence diversity in a community-based sample and among patients sufficiently ill to warrant testing for virus, no significant difference in outcomes of hospitalization or death could be discerned between clades in this sample.
Journal ArticleDOI
Molecular and Clinical Characterization of Human Adenovirus E4-Associated Conjunctivitis.
TL;DR: In the NVC-422 randomized controlled clinical trial comparing auricloscene to placebo, clinical signs and symptoms at presentation and day 18 endpoint were compared with the larger cohort of 262 subjects with conjunctivitis due to AdV D8 as discussed by the authors.